Vimarsana
Biggest News Aggregation in the World

Page 8 - Cleo Lee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cleo Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cleo Lee Today - Breaking & Trending Today

Medigen to apply to Australian agency for provisional approval of its vaccine - Vimarsana News

Medigen to apply to Australian agency for provisional approval of its vaccine

Medigen Vaccine Biologics Corp (高端疫苗) yesterday said it would apply to the Australian Therapeutic Goods Administration (TGA) for provisional approval of its COVID-19 vaccine in the near term, after obtaining a provisional determination from the agency. A provisional approval in Australia is similar to emergency use authorization in other countries, Medigen said in a statement. Medigen would provide the regulator with all required data, including those from its phase 2 clinical trials conducted in Taiwan and from its clinical trials conducted in other countries, such as Paraguay, spokes...

WHO selects Taiwan's Medigen COVID-19 vaccine for international trial - Vimarsana News

WHO selects Taiwan's Medigen COVID-19 vaccine for international trial

Taipei, Oct. 26 (CNA) A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.

Medigen COVID-19 vaccine trial in Paraguay begins - Vimarsana News

Medigen COVID-19 vaccine trial in Paraguay begins

Medigen Vaccine Biologics Corp (高端疫苗) on Tuesday said that it had recruited more than 300 participants for its phase 3 clinical trial of its COVID-19 vaccine in Paraguay. The company said it expects to finish giving first doses to 330 people this week and that it had planned to recruit all 1,000 participants for the trial in the third quarter, but the recruitment was delayed because its research partner, the National University of Asuncion in Paraguay, could not obtain enough AstraZeneca COVID-19 vaccines before Wednesday last week. The phase 3 trial is using immunobridging to compare ...

COVID-19: Medigen to develop next-gen vaccine on Beta variant - Vimarsana News

COVID-19: Medigen to develop next-gen vaccine on Beta variant

Medigen Vaccine Biologics Corp (高端疫苗) is planning to develop its next-generation COVID-19 vaccine by using a sequence of the Beta variant of SARS-CoV-2, which was first detected in South Africa, the company said in a statement on Thursday. The company’s animal tests showed that a booster shot built on the Beta variant prompted immunity in hamsters against all variants of the virus, it said. Medigen is seeking to conduct human trials for the vaccine in Taiwan, but it would not necessarily need to conduct phase 1 clinical trials, the earliest stage involving human testing, company spok...

《TAIPEI TIMES》 Medigen optimistic over trials - 焦點 - Vimarsana News

《TAIPEI TIMES》 Medigen optimistic over trials - 焦點

根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw 《TAIPEI TIMES》 Medigen optimistic over trials From left, Medigen Vaccine Biolog...

Source: ltn.com.tw